Literature DB >> 28572656

Hepatitis B Core-Related Antigen: A Possible Indicator for the Termination of Prophylactic Nucleos(t)ide Analogue Therapy in Patients After Immunosuppressive Therapy.

Hienori Toyoda1, Takashi Kumada1, Toshifumi Tada1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28572656     DOI： 10.1038/ajg.2017.68

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  3 in total

1.  Association of Hepatitis B Core-Related Antigen With Hepatitis B Virus Reactivation in Occult Viral Carriers Undergoing High-Risk Immunosuppressive Therapy.

Authors:  Wai-Kay Seto; Danny Ka-Ho Wong; Thomas Sau-Yan Chan; Yu-Yan Hwang; James Fung; Kevin Sze-Hang Liu; Harinder Gill; Yuk-Fai Lam; Ka-Shing Cheung; Albert K W Lie; Ching-Lung Lai; Yok-Lam Kwong; Man-Fung Yuen
Journal:  Am J Gastroenterol       Date:  2016-09-20       Impact factor: 10.864

Review 2.  Hepatitis B core-related antigen assay is useful for monitoring the antiviral effects of nucleoside analogue therapy.

Authors:  Eiji Tanaka; Akihiro Matsumoto; Kaname Yoshizawa; Noboru Maki
Journal:  Intervirology       Date:  2008-06-10       Impact factor: 1.763

3.  Correlation between serum hepatitis B virus core-related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients.

Authors:  Fumitaka Suzuki; Hideo Miyakoshi; Mariko Kobayashi; Hiromitsu Kumada
Journal:  J Med Virol       Date:  2009-01       Impact factor: 2.327
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.